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ABSTRACT 
Nowadays, esterases represent high growth potential in the World Industrial Enzymes Market. The industrial applications of esterases provide an 
immense contribution to the eco-friendly approaches towards nature as also in the food, textile industries as additives in detergents, agrochemical 
(herbicides, insecticides) industries, and bioremediation. The current review is focused mainly on different medical aspects of esterases because they 
find implications in treatment of cancer, cardiovascular diseases and neuropathy. The role of esterase has been observed in the treatment of hereditary 
angioedema (HAE). The arylesterase (ARE) has been found to show antioxidant activity in plasma cells and its low activity resulted in multiple 
myelomas accounting for 1% of neoplastic diseases and 13% of hematological malignancies in U. S. A. Lung cancer is one of the most lethal forms of 
cancers and reports have indicated that tumors of the lung, colon and liver had high esterase expressions and therefore could be exploited for selective 
drug conversion using an ester prodrug strategy. Human serum paraoxonase (PON1) and arylesterase (ARE) are lipophilic antioxidant enzymes. 
Hypercholesterolaemia has been found to be associated with reduced PON1 enzyme activities and patients are under increased oxidative stress. 
Esterases from animal and plant origins have been used as effective drugs and as detection probes for toxic compounds using chiral technology. 
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INTRODUCTION 
Esterases belong to the family of lipolytic hydrolases and catalyze 
the hydrolysis and the formation of ester bonds [1]. Esterases 
catalyze esterification, transesterification and interesterification 
reactions [2]. These enzymes affect the rates of reversible reactions 
depending on the thermodynamics that means in an organic phase 
esterase favors ester formation and in the aqueous phase carry out 
ester hydrolysis [3]. Esterases differ from lipases mainly on the basis 
of substrate specificity and interfacial activation [4]. Esterases 
hydrolyze short chain carboxylic acids (less than C-12) while lipases 
hydrolyze insoluble long chain (greater than C-12) triglycerides [5-
7]. These are attractive biocatalysts as they do not require cofactors 
[8]. The Enzyme Commission number assigned to esterase is E. C 
3.1.1. x, where x depends on the substrate [9]. Esterases play a major 
role in the degradation of natural materials and industrial pollutants, 
viz., cereal wastes, plastics and other toxic chemicals. A newly 
isolated gene Car EW from Bacillus sp. K91 was shown to be 
responsible for the catalytic hydrolysis and detoxification of di 
isobutyl phthalate (DiBP) to phthalic acid (PTH) that can be 
completely mineralized [10]. Esterase is useful in the synthesis of 
optically pure compounds, perfumes and antioxidants [11]. The 
EstB28 was the first esterase to be characterized from the wine-
associated lactic acid bacterium, Oenococcus oeni [12] and esters are 
quantitatively significant constituents of wine [13]. A novel 
extracellular esterase from Salimicrobium sp. LY19 has exhibited 
thermo-stable, alkali-stable, halo-tolerant and organic solvent-
tolerant properties that could be exploited in industrial organic 
synthesis reactions [14]. As applications of esterases are found in 
various fields and due to growing interest in this enzyme, various 
aspects of esterases have been reported mainly in the avenues of 
distribution, quantitation, production, targeted synthesis, 
purification and molecular biology. Esterases are less explored 
enzymes and this is the first review exploring recent highly valuable 
research and application in medicine.  
Source and production of esterase 
Esterases are widely distributed in animals, plants and microorganisms 
but microbial sources are considered as prominent for esterase 
production. The microbial sources include bacteria, fungi, yeasts and 
actinomycetes. Samples such as cheese surface [15], oil contaminated 
area of city garbage or marine squid have been used for microbial 
esterase production [16]. The biochemical properties of some of the 
microbial esterases are given in table 1. Different sources yield different 
esterases such as carboxyl esterase, choline esterase, acetyl xylan 
esterase, aryl esterase, phosphotri-esterase, phenolic esterase, pig liver 
esterase, acetylcholine esterase and tannin esterase [11].  
 
Table 1: Biochemical properties of different esterases from different microbial sources 

















6.5 Upto 45 36.7 [19] 
Aspergillus awamori Acetylesterase 7.0 Upto 40 31 [20] 
Metagenome Pyrethroid hydrolyzing 7.0 40 31 [21] 
Bacillus subtilis NRRL 365 Carboxyl esterase I   36 [5] 
Bacillus subtilis NRRL 365 Carboxyl esterase II   105 [5] 
Rhodosporidium toruloides Cephalosporin 
Esterase 
6.0 25 80 [22] 
Aureobasidium pullulans Feruloyl esterase 6.7 60-65  [23] 
Thermoanaero-bacterium 
sp. Strain JW/SL-YS485 
Acetyl xylan 
esterase I 
7.0 80 195 [24] 
Pseudomonas stutzeri Strain A1501 Esterase 9.0 50 - [25] 
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For example, pancreatic cholesterol esterase catalyzes the 
hydrolysis of cholesterol esters into their component sterols and 
fatty acids, also, the reaction catalyzed is shown in (fig. 1) [26]. 
Cholesterol esterase is an important enzyme and functions to 
control the bioavailability of cholesterol from dietary cholesterol 
esters, transport of free cholesterol to the enterocyte and absorption 
of free cholesterol [27]. 
 
Fig. 1: The reaction is showing hydrolytic cleavage of 
cholesterol ester by cholesterol esterase (cholesteryl ester 
hydrolase) [27] 
 
Esterases from an extremophilic origin, in particular, are most 
robust biocatalysts because they can function under the harsh 
conditions of industrial processes owing to their inherent 
thermostability and resistance towards organic solvents, which 
combined with their high chemo-, regio-and enantioselectivity make 
them very attractive biocatalysts for a variety of industrial 
applications [28]. In most cases, such substrates contain the required 
inducer. On the other hand, phosphotriesterase from Pseudomonas 
montelli [29], which is regulated by phosphate and carbon sources, 
thermostable intracellular esterase from Bacillus sp. and tributyrin-
induced esterase in Lactobacillus casei [30] differ from the enzymes 
produced by Aspergillus sp. or Sporotrichum sp. Esterases are produced 
in many ways and there is often no need for high purity [31]. However, 
the wide spectrum of application and the growing demand for esterase 
can be satisfied by the development of suitable production strategies.  
Medical applications of esterases 
Application in chiral drug synthesis 
Esterases are mainly used in the synthesis of optically pure 
compounds and fine chemicals of interest in the pharmaceuticals 
such as antibiotics and anti-inflammatory drugs [28]. In 
pharmaceutical industries, esterase produced chiral drugs such as 
anti-inflammatory drugs which have been used as pain killing agents 
[32]. An esterase from Trichosporon brassicae has been used 
extensively for the production of optically pure (S)-and/or (R)-
ketoprofen [2-(3 benzoylphenyl) propionic acid] (fig. 2), which is 
very effective in the reduction of inflammation and relief of pain 
resulting from arthritis, sunburn, menstruation and fever [33]. 
Stereospecific conversions have been reported in the production of 
pharmaceutical intermediates with respect to taxol semi-syntheses, 
viz., throumboxane-A2-antagonist, acetylcholine esterase inhibitors, 
anti-cholesterol drugs [34]. An esterase from Pseudomonas stutzeri 
strain A1501 has been characterized with unique stereospecific 
properties to be useful in industrial chiral synthesis [25]. 
 
Fig. 2: The structure of Ketoprofen-pain-killer and anti-
inflammatory drug [35] 
Application in neuropathy 
Neuropathy 
 
is a disease affecting nerves, which may impair 
sensation, movement, gland or organ function. NTE is a membrane-
bound protein found in neurons of vertebrates and plays a central 
role in both chemically induced and spontaneously occurring 
neurological diseases [36]. During screening of neurotoxicity of 
potential organophosphorous neurotoxicants (paraoxon,malaoxon, 
chlorpyrifos-oxon, dichlorovos, and trichlorfon) on neuroblastoma 
cell lines (human SHSY5Y and murine NB41A3), it was 
demonstrated that acute and delayed neurotoxicity is consequence 
of differential inhibition of target esterases acetylcholinesterase 
(AChE) and NTE by organophosphorous compounds [37]. The role 
of NTE in neurodegeneration was experimentally proved in NTE 
knockout mice generated by cre-loxP site-specific recombination 
and had revealed that NTE absence resulted in hippocampal and 
thalamic neuronal vacuolation and extensive membrane deformities 
[38]. Studies in mammalian cell line and yeasts have revealed that 
loss of NTE phospholipase activity and accumulation of 
phosphatidylcholine due to organophosphorous induced delayed 
neuropathy (OPIDN) resulted in endoplamic reticulum malfunction 
and hindrance in axonal transport [39]. This is explained in the 
pathway (fig. 3) which describes that phosphatidylcholine (PtdCho) 
at the cytoplasmic face of the endoplasmic reticulum membrane is 
deacylated by NTE to form soluble products, free fatty acids (FFA) 
and glycerophosphocholine (GroPCho) but inhibition of NTE by 
organophosphates resulted in OPIDN [40]. Recently, the role of NTE 
was reviewed in metabolism and pathophysiology, NTE mediated 
production of glycerophosphocholine which is an abundant renal 
medullary organic osmolyte protects renal medullary cells from the 
high interstitial concentrations of NaCl and urea [41]. The role of 
NTE has been recognized to control the cytotoxic accumulation of 
lysophospholipid in mammalian membranes and to maintain lipid 
bilayer fluidity. The fluorescence recovery after pattern 
photobleaching (FRAPP) was used to study the effect of the 
hydrolysis of 1-palmitoyl-2-hydroxy-sn-glycero-3-phosphocholine 
(p-lysoPC) by the catalytic domain of NTE on different supported 
bilayer membranes (sBLMs) formulations and it was concluded that 
there was a significant decrease in the fluidity of sBLMsm 
reconstituted on silica [42].  
Fig. 3: This diagram shows a relationship between NTE and 
OPIDN [40] 
 
Application in anti-tumour and cancer treatment 
Various lethal forms of cancer have been recognized and lung cancer 
is one of them. Recent chemotherapeutic strategies against lung 
cancer lack broad specificity and efficiency. A biocompatible and 
biodegradable poly (ethylene glycol)-b-poly (D, L-26 lactic acid) 
(PEG-b-PLA) micelle-delivered β-lap-dC3 and 28-dC6 prodrugs 
nanotherapeutics were converted to β-lapachone (β-lap) using 
Arafat et al. 
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porcine liver esterase (PLE). The β-lapachone produg showed 
antitumor efficacy and long-term survival using cytotoxicity assays 
on A549 and H596 lung cancer cells [43]. In a neural stem cells 
(NSCs)-derived enzyme/prodrug therapy (NDEPT), anti-tumor 
effect of NSCs expressing carboxylesterase (CE) was proved to treat 
primary lung cancer or metastatic lung cancer in the brain [44]. 
Neural stem cells (NSCs) expressing rabbit carboxylesterase (F3. CE) 
could inhibit the growth of A549 human non-small cell lung 
adenocarcinoma cells in vitro and in vivo and thus delivering 
therapeutic genes to brain tumors has been considered as an 
effective treatment for lung cancer brain metastases [45]. 
Application in biosensor fabrication 
In the fabrication of a cholesterol based biosensor, cholesterol 
esterase in conjunction with cholesterol oxidase and peroxidase was 
immobilized onto polyaniline films and has been used as sensing 
elements in estimation of cholesterol concentration and resulted in 
improved shelf-life of biosensor electrodes [46]. The estimation of 
metabolites such as glucose, urea, lactate, and cholesterol in the 
blood sample is important in clinical diagnostics and prevention of a 
number of clinical disorders such as hypertension, arteriosclerosis, 
cerebral thrombosis and coronary heart diseases [47, 48].  
Recently, highly sensitive fluorogenic esterase probes derived from 
the far-red fluorophore 7-hydroxy-9H-(1, 3 dichloro-9, 9-
dimethylacridin-2-one) (DDAO) have been used to detect low 
picogram amounts of PLE activity in mycobacterial lysates during 
different stages of tuberculosis infection [49]. Mycobacterium 
tuberculosis esterases have the distinct role in pathogenesis [50] and 
this has been difficult to characterize them because most form 
inclusion bodies in heterologous hosts [51]. In a recent report, 
esterase has been used with ferrocene capped gold nanoparticle for 
cholesterol detection in blood samples [52]. 
HAE treatment 
HAE is an autosomal dominant disease, characterized by episodes of 
painful excess fluid build-up, typically affecting the bowels, face and 
upper airway, body trunk, genitalia, and extremities [53]. HAE is 
caused by a deficiency in C1 esterase inhibitor (C1-INH) with no 
differences in prevalence based on gender or race [53]. Management 
of HAE may include treatment for acute attacks, or short-or long-
term prophylaxis for prevention of HAE attacks [54]. In the case of a 
patient with HAE that included hypovolemic shock, ascites, severe 
sepsis from nosocomial pneumonia, renal and respiratory failure 
was given a trial of daily intravenous infusion of Human plasma-
derived C1 esterase inhibitor (pdC1-INH) concentrate, his clinical 
status was found to be improved, particularly renal function [55]. 
Thus, human plasma-derived C1 esterase inhibitor (pdC1-INH) is 
indicated for the treatment of both HAE attacks and prevention of 
HAE episodes in patients undergoing medical treatment. 
Application in gene therapy 
Gene therapy involves replacing a defective gene in the body with a 
healthy one. This can be done by removing cells from the body 
using genetic 
Application in treatment of hypercholesterolemia 
engineering techniques to change defective sequences 
in the DNA, then reinserting the cells instead of using drugs or 
surgery. A replacement therapy has also been designed for raising 
serum levels of PON1 paraoxonase/arylesterase enzymes by using a 
gene delivery vector for hydrolytic destruction of organophosphate 
before it can enter the brain and cause toxicity [56]. 
Hypercholesterolemia is characterized by very high levels of 
cholesterol in the blood and it is an established risk factor for 
atherosclerosis and coronary heart disease (CHD) [57] in humans. In 
a report while studying the action of cholesterol esterase it was 
found that cholesterol esterase targeted inhibitors could be useful 
therapeutics for limiting cholesterol absorption [58]. 
Application in diagnostics 
Multiple myelomas is a cancer of the plasma cells and it accounts for 
1% of neoplastic diseases and 13% of hematological malignancies in 
U. S. A. In multiple myeloma patients, it was reported that activity of 
arylesterase was significantly lower as compared to controls and 
patients suffered from high oxidative stress [59]. A thermostable 
bacterial cocaine esterase was identified to degrade cocaine in 
rodents and provide protection against convulsant and lethal effects 
of cocaine, thus preventing adverse effects of cocaine on the central 
nervous system [60]. The role of esterases has also been identified in 
implementing malaria control strategies, where they help in insecticide 
bendiocarp resistance in Anopheles gambiae Tanguieta [61]. The 
presence of leukocyte esterase in the synovial fluid has recently been 
proposed as a marker for periprosthetic joint infection [62]. 
Other applications of esterases 
Nowadays, esterases represent high growth potential in the World 
Industrial Enzymes Market.  
 
Table 2: Applications of different esterases in various fields 
Esterase type Application Reference 
i. Acetylcholinesterase Development of new drugs for schistosomiasis biomarker for detection of organophosphates in a marine 




ii. Arylesterase Flavor development in food and alcoholic beverages. [67] 
iii. Carboxylesterases Helpful in degradation of ethylene glycol di benzoate ester, lowering toxicity of malathion, hydrolysis of 
aspirin and organophosphorus insecticides, determining metabolic resistances 









Degradation of poly (ether-urethane), prerequisite for working on sodium pump in various tissues. [75, 76] 
vi. Cinnamoyl ester 
hydrolase 
Plant cell wall degradation [77] 
vii. Erythromycin 
esterase 
Development of clinical medicine in human, 
poultry and fish. 
[78] 
viii. Ferulic acid 
esterase 
Release of the ferulic acid. [79] 
 
ix. Feruloyl esterase Synthesis of pentyl ferulate ester used in 
cosmetics and perfumes industries, decolorization of paper mill effluent. 
[80, 81] 
x. Methyl jasmonate 
esterase 
Hydrolysis of methyl esters of abscisic acid, indole-3-acetic acid and fatty acids. [82] 
xi. Phosphotriesterase Hydrolysis of products of coumaphos and coroxon. [83] 
Arafat et al. 
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They have many applications in the food industry (modification of 
fats to develop organoleptic and nutritional qualities) and the paper 
industry (removal of pitch from paper pulp), as additives in 
detergents, synthesis of biopolymers, biodiesel production, cosmetic 
(flavor and fragrance compounds) and agrochemical (herbicides, 
insecticides) industries, and bioremediation and waste treatment 
[28]. In particular, carboxylesterases play an important role in the 
detoxification of xenobiotics and many agrochemicals and 
insecticides [63]. Some of the applications of different esterases 
have been given in table 2. 
CONCLUSION 
Esterases are being used from diagnostics to the treatment of cancer, 
neurodegeneration diseases as well as other chronic diseases such 
as hereditary angioedema and hypercholesterolemia. The demand 
for these enzymes in medicine is now greatly increasing due to their 
role in the production of β-lap prodrug nanotherapeutics for the 
treatment of neural stem cell cancer, chiral drug synthesis and gene 
therapy. This is the only review on medical aspects of esterases 
despite the fact that these enzymes are extensively exploited in 
medicine. Microbial esterases have been better exploited in 
microbial fermentations using recombinant and protein engineering 
techniques but esterases from animal and plant origins are also used 
as effective drugs. Esterases are very potent eco-friendly enzymes as 
they also have immense application in detoxification of xenobiotic 
and bioremediation but their role in medicine is very important. 
There is a very less literature available for esterases as compared to 
lipases and thus, a great need to explore these enzymes and the 
future scope of research in this field is highly valuable.  
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